Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norwegian Mycelium
Oslo, Oslo, Norwaynomy.no ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Norwegian Mycelium has developed scalable fungal fermentation technologies to convert food industry side streams into high-value mycoprotein and other sustainable ingredients for the food and animal feed industries. Their platform is proven at commercial scale with strategic partnerships in Europe and Japan.
- Modalities
- Microbial therapyFungal fermentation technology
- Industry
- Non-Drug Biotech
02
Partnerships
Nippon Beet Sugar Manufacturing Co., Ltd. ("Nitten")Hokuren (Hokkaido’s largest farmer cooperative)
Beyond the preview
Go deeper on Norwegian Mycelium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Norwegian Mycelium.